ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 124 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,248,000 | +62.3% | 206,958 | -3.1% | 0.00% | 0.0% |
| Q3 2019 | $769,000 | +37.8% | 213,522 | +2.6% | 0.00% | +100.0% |
| Q2 2019 | $558,000 | -9.4% | 208,192 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $616,000 | +85.0% | 208,192 | -0.6% | 0.00% | 0.0% |
| Q4 2018 | $333,000 | -56.8% | 209,470 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $771,000 | +30.9% | 209,470 | +0.7% | 0.00% | 0.0% |
| Q2 2018 | $589,000 | -23.1% | 208,095 | +0.8% | 0.00% | -50.0% |
| Q1 2018 | $766,000 | +44.3% | 206,482 | +11.9% | 0.00% | +100.0% |
| Q4 2017 | $531,000 | -36.7% | 184,465 | -1.3% | 0.00% | -50.0% |
| Q3 2017 | $839,000 | -11.9% | 186,873 | -9.9% | 0.00% | 0.0% |
| Q2 2017 | $952,000 | -2.0% | 207,360 | -10.1% | 0.00% | 0.0% |
| Q1 2017 | $971,000 | -2.7% | 230,760 | -4.5% | 0.00% | 0.0% |
| Q4 2016 | $998,000 | -50.3% | 241,660 | -2.5% | 0.00% | -50.0% |
| Q3 2016 | $2,008,000 | +4.6% | 247,960 | +0.8% | 0.00% | 0.0% |
| Q2 2016 | $1,919,000 | -0.2% | 246,060 | -1.2% | 0.00% | 0.0% |
| Q1 2016 | $1,923,000 | -18.2% | 249,060 | +14.3% | 0.00% | -33.3% |
| Q4 2015 | $2,351,000 | +59.0% | 217,878 | +1.8% | 0.01% | +50.0% |
| Q3 2015 | $1,479,000 | -22.2% | 214,006 | -0.3% | 0.00% | -20.0% |
| Q2 2015 | $1,902,000 | -7.7% | 214,706 | +2.8% | 0.01% | 0.0% |
| Q1 2015 | $2,060,000 | -6.8% | 208,885 | +15.8% | 0.01% | 0.0% |
| Q4 2014 | $2,210,000 | +23.9% | 180,385 | +0.9% | 0.01% | +25.0% |
| Q3 2014 | $1,784,000 | +33.3% | 178,721 | +1.1% | 0.00% | +33.3% |
| Q2 2014 | $1,338,000 | +133.1% | 176,707 | +1.3% | 0.00% | +50.0% |
| Q1 2014 | $574,000 | -0.9% | 174,507 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $579,000 | +10.3% | 174,507 | +0.4% | 0.00% | 0.0% |
| Q3 2013 | $525,000 | -61.8% | 173,807 | +3.3% | 0.00% | -50.0% |
| Q2 2013 | $1,376,000 | +24.6% | 168,258 | +33.2% | 0.00% | 0.0% |
| Q1 2013 | $1,104,000 | – | 126,343 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $57,396,000 | 7.04% |
| HealthInvest Partners AB | 497,807 | $2,096,000 | 3.21% |
| BVF INC/IL | 3,285,400 | $13,832,000 | 2.35% |
| EMORY UNIVERSITY | 486,438 | $2,048,000 | 1.93% |
| Marcus Capital, LLC | 69,400 | $1,751,000 | 1.63% |
| DAFNA Capital Management LLC | 196,500 | $827,000 | 0.70% |
| Orbimed Advisors | 13,107,200 | $55,181,000 | 0.62% |
| Rock Springs Capital Management LP | 1,500,000 | $6,315,000 | 0.36% |
| Spark Investment Management LLC | 710,100 | $2,989,000 | 0.19% |
| TURNER INVESTMENTS LLC | 65,420 | $275,000 | 0.18% |